We have reported that a tumour suppressor microRNA-7-5p, miR-7, could inhibit the TYRO3/phospho-AKT pathway to overcome SR, and is therefore a potential HCC therapeutic [14–16]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.